CMPS Logo

COMPASS Pathways plc (CMPS) 

NASDAQ
Market Cap
$299.68M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
489 of 775
Rank in Industry
33 of 39

Largest Insider Buys in Sector

CMPS Stock Price History Chart

CMPS Stock Performance

About COMPASS Pathways plc

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United …

Insider Activity of COMPASS Pathways plc

Over the last 12 months, insiders at COMPASS Pathways plc have bought $0 and sold $28.34M worth of COMPASS Pathways plc stock.

On average, over the past 5 years, insiders at COMPASS Pathways plc have bought $0 and sold $14.37M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

List of Insider Buy and Sell Transactions, COMPASS Pathways plc

2024-10-24Sale10 percent owner
776,565
$0$0-18.97%
2024-10-24Sale10 percent owner
1.55M
$0$00.00%
2024-10-24Sale10 percent owner
1.55M
$0$00.00%
2024-09-26Sale10 percent owner
2.66M
3.3714%
$6.05$16.09M0.00%
2024-05-21Sale10 percent owner
17,800
0.0262%
$7.91$140,759-13.21%
2024-05-21Sale10 percent owner
17,800
0.0262%
$7.91$140,759-13.21%
2024-05-20Sale10 percent owner
13,407
0.0195%
$7.89$105,808-14.03%
2024-05-20Sale10 percent owner
13,407
0.0195%
$7.89$105,808-14.03%
2024-05-03Sale10 percent owner
37,523
0.0663%
$8.82$330,904-19.04%
2024-05-03Sale10 percent owner
37,523
0.0663%
$8.82$330,904-19.04%
2024-05-02Sale10 percent owner
19,243
0.0312%
$8.29$159,528-16.04%
2024-05-02Sale10 percent owner
19,243
0.0312%
$8.29$159,528-16.04%
2024-04-17Sale10 percent owner
21,700
0.0361%
$8.78$190,615-17.99%
2024-04-17Sale10 percent owner
21,700
0.0361%
$8.78$190,615-17.99%
2024-04-16Sale10 percent owner
47,761
0.0749%
$8.53$407,349-19.93%
2024-04-16Sale10 percent owner
47,761
0.0749%
$8.53$407,349-19.93%
2024-04-01Sale10 percent owner
51,500
0.082%
$8.96$461,332-25.62%
2024-04-01Sale10 percent owner
51,500
0.082%
$8.96$461,332-25.62%
2024-03-28Sale10 percent owner
51,500
0.0865%
$8.65$445,552-13.34%
2024-03-28Sale10 percent owner
51,500
0.0865%
$8.65$445,552-13.34%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Tcg Crossover Management Llc$32.1M5.643.86M0%+$00.05
Citadel Advisors LLC$32.08M5.643.86M+146.41%+$19.06M0.02
Millennium Management LLC$26.84M4.723.23M+2,975.2%+$25.96M0.02
Paradigm BioCapital Advisors LP$19.89M3.52.39M+5.52%+$1.04M0.72
ARK Investment Management LLC$17.98M3.162.16M-17.48%-$3.81M0.06
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.